Safety and efficacy of single-balloon enteroscopy in management of gastrointestinal bleeding in patients with a left ventricular assist device

Abstract

Background and study aims Left ventricular assist devices (LVADs) are currently the standard of care in treatment of patients with end-stage heart failure waiting for heart transplant as well as destination therapy for non-transplant candidates. However, patients with LVADs are at increased risk of gastrointestinal bleeding due to the device’s unique effects on hemodynamics. A major source of gastrointestinal bleeding in these patients are gastrointestinal angioectasias located within the small bowel that can only be reached with deep enteroscopy. The goal of our study was to determine the safety and efficacy of single-balloon enteroscopy (SBE) in treating gastrointestinal bleeding in patients with LVADs.

Patients and methods We present a retrospective case series performed on patients with LVADs who underwent SBE to treat episodes of gastrointestinal bleeding. All procedures were performed at Emory University Hospital by a single endoscopist. Patient demographics, diagnosis and treatment of gastrointestinal bleeding, episodes of re-bleeding, and procedure-related complications were examined.

Results A total of 27 SBE procedures performed in 14 patients were reviewed. SBE was performed in an antegrade approach in 89 % (24/27) of cases. Deep intubation was achieved in all antegrade procedures, with the distal jejunum reached in 79 % (19/24) of cases. The diagnostic yield was 78 %. There were no reported complications associated with the procedures.

Conclusions SBE is a safe and effective modality to manage gastrointestinal bleeding in patients with LVADs.

• References

• 1 Morgan JA, Paone G, Nemeh HW. et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012; 31: 715-718
• 2 Suarez J, Patel CB, Felker GM. et al. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail 2011; 4: 779-784
• 3 Demirozu ZT, Radovancevic R, Hochman LF. et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-853
• 4 Aggarwal A, Pant R, Kumar S. et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012; 93: 1534-1540
• 5 Harvey L, Holley CT. et al. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg 2014; 3: 475-479
• 6 Stern DR, Kazam J, Edwards P. et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010; 25: 352-356
• 7 Letsou GV, Shah N, Gregoric ID. et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005; 24: 105-109
• 8 Decker GA, Miller ED, Pasha SF. et al. Deep enteroscopy in patients with left ventricular assist devices: practical and technical considerations. Endoscopy 2010; 42 (Suppl. 02) E194
• 9 Tarzia V, Dal Lin C, Bottio T. et al. Occult gastrointestinal bleeding in patients with a left ventricular assist device axial flow pump: diagnostic tools and therapeutic algorithm. J Thorac Cardiovasc Surg 2012; 143: e28-31
• 10 Edwards AL, Monkemuller K, Pamboukian SL. et al. Utility of double-balloon enteroscopy in patients with left ventricular assist devices and obscure overt gastrointestinal bleeding. Endoscopy 2014; 46: 986-988
• 11 Sarosiek K, Bogar L. et al. An old problem with a new therapy: gastrointestinal bleeding in ventricular assist device patients and deep overtube-assisted enteroscopy. ASAIO J 2013; 59: 384-389
• 12 Kushir VM, Sharma S, Ewald GA. et al. Evaluation of gastrointestinal bleeding after implantation of left ventricular assist device. Gastrointest Endosc 2012; 75: 973-979